Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer☆
To access this article, please choose from the options below
☆ This work has been sponsored by a scientific grant of the Belgian ‘Foundation against cancer, non profit organization’.
PII: S0167-8140(09)00123-6
doi:10.1016/j.radonc.2009.03.013
© 2009 Elsevier Ireland Ltd. All rights reserved.
